• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Austrian Academy of Sciences

Headquarters: Vienna, Austria
Website: http://www.oeaw.ac.at
Year Founded: 1847
Status: N/A

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Oct 1, 2025
Discovery & Translation

Science Spotlight: Lectin-based bispecifics for tumor-specific targeting

BioCentury’s translational roundup also includes enhancers of CAR T cell function and a suite of delivery advances
Read More
BioCentury | Jan 27, 2025
Discovery & Translation

Science Spotlight: Improving safety of live-attenuated vaccines

BioCentury’s roundup of translational innovations also includes base editing for prion disease, a Flagship collab, and six papers with links to newcos
Read More
BioCentury | Feb 2, 2022
Emerging Company Profile

BioCentury’s 2021 class of emerging companies

An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers
Read More
BioCentury | Mar 6, 2021
Emerging Company Profile

Proxygen’s knockout take on targeted protein degradation

Emerging Company Profile: Vienna’s Proxygen is taking a ligase-agnostic approach to finding molecular glues with therapeutic effects
Read More
BioCentury | Jan 3, 2019
Distillery Therapeutics

Cancer; gastrointestinal; inflammation

Read More
BioCentury | Feb 1, 2018
Emerging Company Profile

Non-adherence policy

How Allcyte images B and T cell interactions to predict drug response
Read More
BioCentury | Oct 24, 2017
Distillery Techniques

Disease models

Read More
BioCentury | Sep 28, 2017
Preclinical News

Researchers report first Haplobank data

Read More
BioCentury | May 23, 2017
Distillery Techniques

Assays and screens; imaging

Read More
BioCentury | Feb 23, 2017
Translation in Brief

Folded brain

Brain organoids with surface folding could model neurodevelopmental disorders and diseases
Read More
Items per page:
1 - 10 of 39